Yüklüyor......
Tocilizumab in Systemic Lupus Erythematosus – Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells
OBJECTIVE: To assess the safety of interleukin-6 receptor inhibition and to collect preliminary data on clinical and immunologic efficacy of tocilizumab in patients with systemic lupus erythematosus (SLE). METHODS: In an open label, dose-escalating, Phase I study, 16 patients with mild to moderate d...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3057537/ https://ncbi.nlm.nih.gov/pubmed/20112381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.27221 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|